Kramer Kelly A. 4
4 · GILEAD SCIENCES, INC. · Filed May 9, 2024
Insider Transaction Report
Form 4
Kramer Kelly A.
Director
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2024-05-08+12,648→ 12,648 totalExercise: $64.92Exp: 2034-05-08→ Common Stock (12,648 underlying) - Award
Restricted Stock Unit
2024-05-08+2,310→ 17,594 total→ Common Stock (2,310 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]100% of the restricted stock units vested immediately upon the grant date of May 8, 2024.
- [F3]100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024.